-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Opioids are psychoactive substances derived from opium poppy or synthetic analogues, such as morphine and heroin.
Globally, 69,000 people die from opioid overdose each year.
Opioids are psychoactive substances derived from poppy or synthetic substances with similar effects, such as morphine, heroin, tramadol, oxycodone and methadone.
Opioids are psychoactive substances derived from poppy or synthetic substances with similar effects, such as morphine, heroin, tramadol, oxycodone and methadone.
Opioid use disorder (OUD) is an important cause of morbidity and mortality in the United States, but many patients with OUD are not receiving treatment.
Opioid use disorder (OUD) is an important cause of morbidity and mortality in the United States, but many OUD patients are not receiving treatment.
management
In the absence of treatment, the estimated incidence of overdose in 5 years was 42,717 times per 100,000 people (4132 fatal and 38585 non-fatal) and 12660 deaths.
It is estimated that methadone treatment can explain 10.
In addition, when criminal justice costs are included, all forms of MAT (including buprenorphine, methadone, and naltrexone) save costs compared to no treatment, saving $25,000 to $105,000 in lifetime costs per person.
When criminal justice costs are included, all forms of MAT (including buprenorphine, methadone, and naltrexone) save costs compared to no treatment, saving $25,000 to $105,000 in lifetime costs per person.
When expanding the use of MAT and adding OEND and CM, the cost of OUD morbidity and mortality can be saved.
references:
airley M, Humphreys K, Joyce VR, et al.
com/journals/jamapsychiatry/article-abstract/2778020" target="_blank" rel="noopener">Cost-effectiveness of Treatments for Opioid Use Disorder.
Leave a message here